Ahmedabad based Cadila pharmaceuticals Limited is one of the largest privately held pharmaceutical companies in India. The company has been manufacturing pharmaceutical products and distributing & selling these products in more then hundred other countries around the world.
About Cadila Pharmaceuticals
Cadila pharmaceutical is a multinational research based pharmaceutical company in India. Shri Indravadan Modi (an Indian Pharmaceuticals industry tycoon) founded the company.
It has more than 6-decades of experience. Cadila’s integrated operations covers total gamut from manufacturing products ranging from API’s-Intermediates, OTC-food supplements, biotechnology products, finished formulations & pharmaceutical machinery.
Most stringent International bodies like WHO-GMP, UK-MHRA, USFDA-API, TGA-Australia, and AIFA-Italy, approve Cadila Pharmaceuticals manufacturing facilities.
International operations of the company have spread across 58 countries including America, Japan, CIS, Africa and Asia.
In the year 1951, Indravadan Ambalal Modi, popularly known as Indravadan Modi quit his job as a chemist and started Cadila Laboratories with his childhood friend Ramanlal Patel.
They started the company in a rented bungalow with a capital of ₹ 25,000. They achieved a turnover of around ₹ 1.25 lakh in its first year.
Demerger of Cadila Laboratories
Both Modi and Patel family decided to split the business in 1995. Two entities were formed 1: Cadila Pharmaceuticals Ltd. & 2: Cadila Healthcare.
1: Cadila Pharmaceuticals was owned and controlled by Shri Indravadan A Modi & his son Dr. Rajiv Modi.
2: Cadila Healthcare was owned and controlled by Shri Ramanbhai Patel & his son Pankaj Patel family.
DR.Rajiv Modi and Indravadan. A. Modi worked hard to run Cadila pharmaceuticals. Now cadila is considered as one of the largest privetly-held pharmaceutical companies in India with the revenue of around ₹ 1200 crore.
The company has its formulation-manufacturing unit at Dholka, Gujarat, Samba, and Jammu India & at Addis Ababa-Ethiopia.
They have 2-API manufacturing facilities are located in Ankleshwar, Gujarat. Manufacturing unit at Dholka and API unit at Ankleshwar are USFDA-certified.
Cadila’s state-of-the-art manufacturing unit at Ethopia is the WHO-cGMP compliant facility.
In Dholka India, Cadila has established a dedicated R&D facility. It is spread over 1,05,000 sq. ft. area. 300-scientists operate it.
They have filed 5-IND dossiers filed with USFDA for pulmonary tuberculosis, prostate cancer, bladder cancer, lung cancer and melanoma. Cadila has submitted 10-ANDAs. They have connection with various industries for research.
Some of them are Department of Biotechnology, UDSC, New Delhi, Lala Ram Sarup Institute of TB & Respiratory diseases, New Delhi, RRL, Jammu; CSIR, New Delhi, Advanced Transfusion Medicine Research Foundation, Ahmedabad; National Institute of Immunology, New Delhi; Trieste, Italy etc.
Cadila Pharmaceuticals Products and Services:
Cadila is the only manufacturer of natural Streptokinase and Hyaluronic Acid products in India. They are the first to introduce Rabeprazole in IV form – ‘Rabeloc’ in the world.
The pharmaceutical company introduced the world’s first boosted-Rifampicin fixed-dose combination for the treatment of Tuberculosis – ‘Risorine’ and world’s first drug combination for prevention of Cardiovascular Diseases – ‘Polycap’ in 2009.
They have recently introduces ‘Mycidac-C’ – first in the class active immunotherapy as well as drug targeting Desmocollin for the patients suffering from Non-Small Cell Lung Cancer (NSCLC).
Here are some of the top brands of the company Rabiloc, Trigan-D, Mycobutol and Sepsivac, Haem Up, Vasograin, Tricort, Fludac, Aciloc, Envas, Calcirol etc.
Cadila pharmaceuticals subsidiaries:
- Apollo Hospitals International Ltd.
- Cadila Pharmaceuticals Sweden AB
- Satellite Overseas (Holdings) Limited
- CPL Inc
- Kadera Yakuhin Ltd
Specialties: Bulg Drugs/API, Finished Formulations, Discovery Research Services, Pre-Clinical/Clinical Trials, Contract Manufacturing, Agro products, Pharma Machinery, generic drugs.
Cadila Pharmaceuticals formed a partnership with a Norwegian start-up from in 2019.
They named it Serca Pharmaceuticals. It develops new treatment for heart patients.
Awards and Recognition:
Following are the list of awards and recognitions achieved by Cadila.
- WorldStar Packaging Award in 2018
- TISS LeapVault CLO Award in 2019
- Observenow Future of Workplace Award in 2019
- Great Place to Work Certified in 2020
Here you can find the company information of Cadila Pharmaceuticals Limited such as a business address, Manufacturing Plants, and contact Numbers of the company, etc.. At Suger Mint, the company listed in the pharmaceutical company category..
Corporate Offices & Manufacturing Plants:
Sarkhej-Dholka Road, Bhat, Ahmedabad, India, 382210
Contact Numbers: +91 2718 225039, +91 2718 225001
Dholka Manufacturing Plant:
Survey No. 1389, Trasad Road, Dholka, Ahmedabad, India, 382225
Contact Numbers: +91 2714 220315, 2714 221481
Ankleshwar API SBU:
294, GIDC Estate, Ankleshwar, India, 393002
Contact Numbers: +91 2646 250051, 2646 223846
Jammu Manufacturing Plant
IGC, Phase-1, SIDCO, Samba, Jammu, J&K, 184121
Contact Numbers: +91 01923 246981